Page last updated: 2024-10-16

bis(4-nitrophenyl)phosphate and Disease Models, Animal

bis(4-nitrophenyl)phosphate has been researched along with Disease Models, Animal in 1 studies

bis(4-nitrophenyl)phosphate: RN given refers to parent cpd

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" In the other two routes of administration via the tail vein and hepatic portal vein, diammonium glycyrrhizinate (15 mg kg(-1)) did not affect any of the pharmacokinetic parameters of aconitine (0."1.35Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism. ( Chen, L; Chen, YX; Davey, AK; Liu, XQ; Wang, JP; Yang, J, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L1
Yang, J1
Davey, AK1
Chen, YX1
Wang, JP1
Liu, XQ1

Other Studies

1 other study available for bis(4-nitrophenyl)phosphate and Disease Models, Animal

ArticleYear
Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism.
    Xenobiotica; the fate of foreign compounds in biological systems, 2009, Volume: 39, Issue:12

    Topics: Aconitine; Administration, Oral; Animals; Biological Transport; Cyclosporine; Disease Models, Animal

2009